These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3296867)

  • 1. A comparison of albuterol and metaproterenol nebulizer solutions.
    Habib MP; Campbell SC; Shon BY; Pinnas JL
    Ann Allergy; 1987 Jun; 58(6):421-4. PubMed ID: 3296867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction.
    Deenstra M; Zanen P; Gusdorf CF
    Arzneimittelforschung; 1988 Oct; 38(10):1490-1. PubMed ID: 3058131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
    Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
    Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulized salbutamol in life-threatening asthma: is IPPB necessary?
    Fergusson RJ; Carmichael J; Rafferty P; Willey RF; Crompton GK; Grant IW
    Br J Dis Chest; 1983 Jul; 77(3):255-61. PubMed ID: 6351888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral salbutamol with reproterol in reversible airway obstruction.
    Dubey GR; Dabholkar SV; Kamat SR; Mahashur AA; Shah SP; Sonaje AG; Athawale SS
    J Assoc Physicians India; 1986 Mar; 34(3):179-82. PubMed ID: 3525508
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
    Baronti A; Grieco A; Vibelli C
    Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
    Duarte AG; Momii K; Bidani A
    Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of airways obstruction by continuous nebulization with and without assisted ventilation.
    Simonsson BG; Arvidsson I; Haldeborg M; Månsson A
    Scand J Respir Dis Suppl; 1977; 101():103-7. PubMed ID: 343232
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of nebulized beta 2-adrenergic agonists on pulmonary mechanics in anesthetized patients with chronic obstructive pulmonary disease.
    Vichitvejpaisal P; Joshi GP; Kumar S; White PF
    J Med Assoc Thai; 1996 Dec; 79(12):779-84. PubMed ID: 9071082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients.
    Morley TF; Marozsan E; Zappasodi SJ; Gordon R; Griesback R; Giudice JC
    Chest; 1988 Dec; 94(6):1205-10. PubMed ID: 3191761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuterol delivery during noninvasive ventilation.
    Branconnier MP; Hess DR
    Respir Care; 2005 Dec; 50(12):1649-53. PubMed ID: 16318646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction. Comparison of two delivery methods.
    Salzman GA; Steele MT; Pribble JP; Elenbaas RM; Pyszczynski DR
    Chest; 1989 May; 95(5):1017-20. PubMed ID: 2707058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison of two delivery methods on the bronchodilator effects of beta 2-stimulant].
    Kishida M; Suzuki I; Koshibu T; Matsumoto H; Uchiyama Y; Kabayama H; Nagayama T; Sasamoto A; Aoki T
    Arerugi; 1996 Jun; 45(6):542-5. PubMed ID: 8776948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit.
    Ballard J; Lugo RA; Salyer JW
    Respir Care; 2002 Jan; 47(1):31-8. PubMed ID: 11749685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction.
    Turner JR; Corkery KJ; Eckman D; Gelb AM; Lipavsky A; Sheppard D
    Chest; 1988 Mar; 93(3):476-81. PubMed ID: 3342656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bronchodilator response to albuterol administered by the OptiHaler, the AeroChamber, or by metered dose inhaler alone.
    Nelson HS; Loffert DT
    Ann Allergy; 1994 Apr; 72(4):337-40. PubMed ID: 8154632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma.
    Salo D; Tuel M; Lavery RF; Reischel U; Lebowitz J; Moore T
    J Emerg Med; 2006 Nov; 31(4):371-6. PubMed ID: 17046476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.